By Year 
A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment.
Young, Arabella; Ngiow, Shin Foong; Gao, Yulong; Patch, Ann-Marie; Barkauskas, Deborah S; Messaoudene, Meriem; Lin, Gene; Coudert, Jerome David; Stannard, Kimberley A; Zitvogel, Laurence; Degli-Esposti, Mariapia A; Vivier, Eric; Waddell, Nicola; Linden, Joel; Huntington, Nicholas D; Souza-Fonseca Guimaraes, Fernando; Smyth, Mark J
CANCER RESEARCH - 1/12/2017
Interleukin-12 from CD103(+) Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis
Mittal, Deepak; Vijayan, Dipti; Putz, Eva M.; Aguilera, Amelia R.; Markey, Kate A.; Straube, Jasmin; Kazakoff, Stephen; Nutt, Stephen L.; Takeda, Kazuyoshi; Hill, Geoffrey R.; Waddell, Nicola; Smyth, Mark J.
Cancer Immunology Research - 1/12/2017
National Health and Medical Research Council of Australia (NHMRC) - 1078671
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.
Garsed, Dale W; Alsop, Kathryn; Fereday, Sian; Emmanuel, Catherine; Kennedy, Catherine J; Etemadmoghadam, Dariush; Gao, Bo; Gebski, Val; Garès, Valérie; Christie, Elizabeth L; Wouters, Maartje C A; Milne, Katy; George, Joshy; Patch, Ann-Marie; Li, Jason; Arnau, Gisela Mir; Semple, Timothy; Gadipally, Sreeja R; Chiew, Yoke-Eng; Hendley, Joy; Mikeska, Thomas; Zapparoli, Giada V; Amarasinghe, Kaushalya; Grimmond, Sean M; Pearson, John V; Waddell, Nicola; Hung, Jillian; Stewart, Colin J R; Sharma, Raghwa; Allan, Prue E; Rambau, Peter F; Traficante, Nadia; McNally, Orla; Mileshkin, Linda; Hamilton, Anne; Ananda, Sumitra; Grossi, Marisa; Cohen, Paul A; Leung, Yee C; Rome, Robert M; Beale, Philip; Blomfield, Penny; Friedlander, Michael; Brand, Alison; Dobrovic, Alexander; Köbel, Martin; Harnett, Paul; Nelson, Brad H; Bowtell, David D L; deFazio, Anna; ,
CLINICAL CANCER RESEARCH - 1/10/2017
Department of Health and Human Services through Victorian Cancer Agency - ECSG15011
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.
Chou, Angela; Froio, Danielle; Nagrial, Adnan M; Parkin, Ashleigh; Murphy, Kendelle J; Chin, Venessa T; Wohl, Dalia; Steinmann, Angela; Stark, Rhys; Drury, Alison; Walters, Stacey N; Vennin, Claire; Burgess, Andrew; Pinese, Mark; Chantrill, Lorraine A; Cowley, Mark J; Molloy, Timothy J; , ; Waddell, Nicola; Johns, Amber; Grimmond, Sean M; Chang, David K; Biankin, Andrew V; Sansom, Owen J; Morton, Jennifer P; Grey, Shane T; Cox, Thomas R; Turchini, John; Samra, Jaswinder; Clarke, Stephen J; Timpson, Paul; Gill, Anthony J; Pajic, Marina
GUT - 1/10/2017
Medical Research Council - MR/N005813/1
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Gao, Yulong; Souza-Fonseca-Guimaraes, Fernando; Bald, Tobias; Ng, Susanna S.; Young, Arabella; Ngiow, Shin Foong; Rautela, Jai; Straube, Jasmin; Waddell, Nic; Blake, Stephen J.; Yan, Juming; Bartholin, Laurent; Lee, Jason S.; Vivier, Eric; Takeda, Kazuyoshi; Messaoudene, Meriem; Zitvogel-, Laurence; Teng, Michele W. L.; Belz, Gabrielle T.; Engwerda, Christian R.; Huntington, Nicholas D.; Nakamura, Kyohei; Hoelzel, Michael; Smyth, Mark J.
NATURE IMMUNOLOGY - 1/09/2017
National Health and Medical Research Council of Australia - 1078671